View Wave Life Sciences Ltd. (WVE) current and estimated P/E ratio data provided by Seeking Alpha.

Shares of Wave Life Sciences WVE surged 74.1% on Wednesday after the company reported positive proof-of-mechanism data from an ongoing early to mid-stage study of its investigational candidate ...

The mean exon skipping was 57%. WVE-N531 was detected in myocyte nuclei in all participants and myogenic stem cells in most participants. Myogenic stem cells are the progenitor cells for new ...

Wave Life Sciences (NASDAQ:WVE) announced positive results from its phase 1b/2a RestorAAtion-2 study using WVE-006 for the treatment of patients with alpha-1 antitrypsin deficiency [AATD].